Predictors of early, recurrent, and intractable seizures in low-grade glioma. Issue 1 (29th August 2020)
- Record Type:
- Journal Article
- Title:
- Predictors of early, recurrent, and intractable seizures in low-grade glioma. Issue 1 (29th August 2020)
- Main Title:
- Predictors of early, recurrent, and intractable seizures in low-grade glioma
- Authors:
- Jo, Jasmin
Nevel, Kathryn
Sutyla, Ryan
Smolkin, Mark
Lopes, M Beatriz
Schiff, David - Abstract:
- Abstract: Background: Seizures are common among patients with low-grade glioma (LGG) and can significantly affect morbidity. We sought to determine the association between the clinical and molecular factors with seizure incidence and refractoriness in LGG patients. Methods: We conducted a retrospective review at the University of Virginia in patients with LGG (World Health Organization, WHO Grade II) evaluated between 2002 and 2015. Descriptive statistics were calculated for variables of interest, and the Kaplan-Meier method was used to estimate survival curves, which were compared with the log-rank test. Results: A total of 291 patients were included; 254 had molecular testing performed for presence of an isocitrate dehydrogenase ( IDH ) mutation and/or 1p/19q codeletion. Sixty-eight percent of patients developed seizures prior to LGG diagnosis; 41% of all patients had intractable seizures. Using WHO 2016 integrated classification, there was no significant difference in seizure frequency during preoperative and postoperative periods or in developing intractable seizures, though a trend toward increased preoperative seizure incidence among patients with the IDH mutation was identified ( P = .09). Male sex was significantly associated with higher seizure incidence during preoperative ( P < .001) and postoperative periods ( P < .001); men were also more likely to develop intractable seizures ( P = .01). Conclusions: Seizures are common among patients with LGG. Differences inAbstract: Background: Seizures are common among patients with low-grade glioma (LGG) and can significantly affect morbidity. We sought to determine the association between the clinical and molecular factors with seizure incidence and refractoriness in LGG patients. Methods: We conducted a retrospective review at the University of Virginia in patients with LGG (World Health Organization, WHO Grade II) evaluated between 2002 and 2015. Descriptive statistics were calculated for variables of interest, and the Kaplan-Meier method was used to estimate survival curves, which were compared with the log-rank test. Results: A total of 291 patients were included; 254 had molecular testing performed for presence of an isocitrate dehydrogenase ( IDH ) mutation and/or 1p/19q codeletion. Sixty-eight percent of patients developed seizures prior to LGG diagnosis; 41% of all patients had intractable seizures. Using WHO 2016 integrated classification, there was no significant difference in seizure frequency during preoperative and postoperative periods or in developing intractable seizures, though a trend toward increased preoperative seizure incidence among patients with the IDH mutation was identified ( P = .09). Male sex was significantly associated with higher seizure incidence during preoperative ( P < .001) and postoperative periods ( P < .001); men were also more likely to develop intractable seizures ( P = .01). Conclusions: Seizures are common among patients with LGG. Differences in preoperative or postoperative and intractable seizure rates by WHO 2016 classification were not detected. Our data showed a trend toward higher seizure incidence preoperatively in patients with IDH -mutant LGG. We describe a unique association between male sex and seizure incidence and intractability that warrants further study. … (more)
- Is Part Of:
- Neuro-oncology practice. Volume 8:Issue 1(2021)
- Journal:
- Neuro-oncology practice
- Issue:
- Volume 8:Issue 1(2021)
- Issue Display:
- Volume 8, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 8
- Issue:
- 1
- Issue Sort Value:
- 2021-0008-0001-0000
- Page Start:
- 40
- Page End:
- 47
- Publication Date:
- 2020-08-29
- Subjects:
- IDH mutation -- low-grade glioma -- seizure -- WHO 2016 classification
Brain -- Tumors -- Periodicals
Brain -- Cancer -- Periodicals
Nervous system -- Cancer -- Periodicals
616.99481005 - Journal URLs:
- http://nop.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/en/ ↗ - DOI:
- 10.1093/nop/npaa054 ↗
- Languages:
- English
- ISSNs:
- 2054-2577
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22032.xml